Literature DB >> 17278223

Gastrointestinal symptoms in a Japanese population: a health diary study.

Yasuharu Tokuda1, Osamu Takahashi, Sachiko Ohde, Masaaki Shakudo, Haruo Yanai, Takuro Shimbo, Shunichi Fukuhara, Shigeaki Hinohara, Tsuguya Fukui.   

Abstract

AIM: To investigate the incidence of gastrointestinal symptoms and the nature of consequent utilization of health care services in a Japanese population.
METHODS: Using self-report, we conducted a prospective cohort study of a nationally representative sample of the Japanese population over a one-month period to determine the incidence of gastrointestinal symptoms of all kinds and resultant health care utilization. Both information on visits to physicians and use of complementary and alternative medicine therapies were collected.
RESULTS: From a total of 3568 in the recruitment sample, 3477 participants completed a health diary (response rate 97%). The data of 112 participants with baseline active gastrointestinal diseases were excluded from the analysis, leaving 3365 participants in the study. The incidence of gastrointestinal symptoms was 25% and the mean number of symptomatic episodes was 0.66 in a month. Abdominal pain, diarrhea, nausea, constipation and dyspepsia were the most frequent symptoms. Female gender, younger age, and low baseline quality of life were risk factors for developing these symptoms. The participants were more likely to treat themselves, using dietary, complementary or alternative medicines, than to visit physicians, except in the case of vomiting.
CONCLUSION: Gastrointestinal symptoms are common in the Japanese population, with an incidence of 25%. Abdominal pain, diarrhea, nausea, constipation and dyspepsia are the most frequent symptoms. Risk factors for developing these symptoms include female gender, younger age, and low baseline quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17278223      PMCID: PMC4065979          DOI: 10.3748/wjg.v13.i4.572

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

2.  The ecology of medical care.

Authors:  K L WHITE; T F WILLIAMS; B G GREENBERG
Journal:  N Engl J Med       Date:  1961-11-02       Impact factor: 91.245

3.  Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Yoko Watanabe; Masatsugu Shiba; Toshio Watanabe; Kazunari Tominaga; Nobuhide Oshitani; Takayuki Matsumoto; Hideki Nishikawa; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 4.029

4.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

5.  Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions.

Authors:  Diane M Turner-Bowker; Martha S Bayliss; John E Ware; Mark Kosinski
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

6.  Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms.

Authors:  K Y Ho; J Y Kang; A Seow
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

7.  Psychosocial risk factors for the onset of abdominal pain. Results from a large prospective population-based study.

Authors:  Smita L S Halder; John McBeth; Alan J Silman; David G Thompson; Gary J Macfarlane
Journal:  Int J Epidemiol       Date:  2002-12       Impact factor: 7.196

8.  SOME PRELIMINARY FINDINGS ON PHYSICAL COMPLAINTS FROM A PROSPECTIVE STUDY OF 1,064,004 MEN AND WOMEN.

Authors:  E C HAMMOND
Journal:  Am J Public Health Nations Health       Date:  1964-01

9.  Redefining abdominal syndromes. Results of a population-based study.

Authors:  L Kay; T Jørgensen
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

10.  Feasibility of collecting diary data from asthma patients through mobile phones and SMS (short message service): response rate analysis and focus group evaluation from a pilot study.

Authors:  Jacob Anhøj; Claus Møldrup
Journal:  J Med Internet Res       Date:  2004-12-02       Impact factor: 5.428

View more
  7 in total

1.  The translation and validation of the Japanese version of the patient assessment of constipation quality of life scale.

Authors:  Akira Tsunoda; Kazutaka Yamada; Masahiro Takano; Hiroshi Kusanagi
Journal:  Surg Today       Date:  2015-05-05       Impact factor: 2.549

2.  ClickDiary: Online Tracking of Health Behaviors and Mood.

Authors:  Ta-Chien Chan; Tso-Jung Yen; Yang-Chih Fu; Jing-Shiang Hwang
Journal:  J Med Internet Res       Date:  2015-06-15       Impact factor: 5.428

3.  Seasonal variation in occurrence of ischemic colitis: a retrospective study.

Authors:  Satoshi Yamanouchi; Sayaka Ogawa; Ryusaku Kusunoki; Youichi Miyaoka; Hirofumi Fujishiro; Naruaki Kohge; Yoshikazu Kinoshita
Journal:  J Int Med Res       Date:  2017-01-25       Impact factor: 1.671

4.  Illness Perception of Patients with Functional Gastrointestinal Disorders.

Authors:  Na-Na Xiong; Jing Wei; Mei-Yun Ke; Xia Hong; Tao Li; Li-Ming Zhu; Yue Sha; Jing Jiang; Felix Fischer
Journal:  Front Psychiatry       Date:  2018-04-12       Impact factor: 4.157

5.  Questionnaire Survey of Bowel Habit in Japanese Medical Personnel.

Authors:  Kotaro Maeda; Yoshikazu Koide; Hidetoshi Katsuno; Tsunekazu Hanai; Koji Masumori; Hiroshi Matsuoka; Tomoyoshi Endo; Yeong Cheol Cheong
Journal:  J Anus Rectum Colon       Date:  2021-07-29

6.  Use of complementary and alternative medicine: a survey in Turkish gastroenterology patients.

Authors:  Taylan Kav
Journal:  BMC Complement Altern Med       Date:  2009-10-26       Impact factor: 3.659

7.  High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan.

Authors:  Shin Fukudo; Hiroto Miwa; Atsushi Nakajima; Yoshikazu Kinoshita; Masanori Kosako; Kenta Hayashi; Hiraku Akiho; Kentaro Kuroishi; Jeffrey M Johnston; Mark Currie; Toshifumi Ohkusa
Journal:  Neurogastroenterol Motil       Date:  2018-10-23       Impact factor: 3.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.